Acarbose, an a‐glucosidase inhibitor for non‐insulin‐dependent diabetes

This publication has 9 references indexed in Scilit:

• PROTECT interim results: a large multicenter study of patients with type II diabetes
  Clinical Therapeutics, 1997
• U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease
  Diabetes, 1995
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
  Diabetes Research and Clinical Practice, 1995
• The Efficacy of Acarbose in the Treatment of Patients with Non–Insulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial
  Annals of Internal Medicine, 1994
• The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1993
• Lymphocytic Infundibuloneurohypophysitis as a Cause of Central Diabetes Insipidus
  New England Journal of Medicine, 1993
• Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet Alone
  Diabetes Care, 1991
• Effect of Acarbose on Carbohydrate and Lipid Metabolism in NIDDM Patients Poorly Controlled by Sulfonylureas
  Diabetes Care, 1990
• Diabetic therapy
  The Medical Journal of Australia, 1982